The Proliferative and Apoptotic Landscape of Basal-like Breast Cancer.
Ontology highlight
ABSTRACT: Basal-like breast cancer (BLBC) is an aggressive molecular subtype that represents up to 15% of breast cancers. It occurs in younger patients, and typically shows rapid development of locoregional and distant metastasis, resulting in a relatively high mortality rate. Its defining features are that it is positive for basal cytokeratins and, epidermal growth factor receptor and/or c-Kit. Problematically, it is typically negative for the estrogen receptor and human epidermal growth factor receptor 2 (HER2), which means that it is unsuitable for either hormone therapy or targeted HER2 therapy. As a result, there are few therapeutic options for BLBC, and a major priority is to define molecular subgroups of BLBC that could be targeted therapeutically. In this review, we focus on the highly proli
SUBMITTER: Alexandrou S
PROVIDER: S-EPMC6387372 | biostudies-literature | 2019 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA